{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T20:58:27Z","timestamp":1788469107287,"version":"build-2803163510"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research (ICMR), Govt. of India","doi-asserted-by":"crossref","award":["5\/3\/8\/24\/2020-ITR"],"award-info":[{"award-number":["5\/3\/8\/24\/2020-ITR"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s10528-024-10921-3","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T05:01:53Z","timestamp":1727067713000},"page":"4057-4112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Matrix Metalloproteinases -2 and -9, Vascular Endothelial Growth Factor, Basic Fibroblast Growth Factor and CD105- Micro-Vessel Density are Predictive Markers of Non-Muscle Invasive Bladder Cancer and Muscle Invasive Bladder Cancer Subtypes"],"prefix":"10.1007","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2106-9694","authenticated-orcid":false,"given":"Rohit","family":"Siddhartha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5813-3012","authenticated-orcid":false,"given":"Apul","family":"Goel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8018-0723","authenticated-orcid":false,"given":"Atin","family":"Singhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4069-8138","authenticated-orcid":false,"given":"Minal","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"issue":"6","key":"10921_CR1","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1016\/j.cell.2019.01.021","volume":"176","author":"RS Apte","year":"2019","unstructured":"Apte RS, Chen DS, Ferrara N (2019) VEGF in signaling and disease: beyond discovery and development. Cell 176(6):1248\u20131264. https:\/\/doi.org\/10.1016\/j.cell.2019.01.021","journal-title":"Cell"},{"issue":"1","key":"10921_CR2","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbcan.2011.10.001","volume":"1825","author":"B Bauvois","year":"2012","unstructured":"Bauvois B (2012) New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta 1825(1):29\u201336. https:\/\/doi.org\/10.1016\/j.bbcan.2011.10.001","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"10921_CR3","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1582-4934.2005.tb00495.x","volume":"9","author":"WD Beecken","year":"2005","unstructured":"Beecken WD, Engl T, Hofmann J, Jonas D, Blaheta R (2005) Clinical relevance of serum angiogenic activity in patients with transitional cell carcinoma of the bladder. J Cell Mol Med 9(3):655\u2013661. https:\/\/doi.org\/10.1111\/j.1582-4934.2005.tb00495.x","journal-title":"J Cell Mol Med"},{"key":"10921_CR4","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1038\/35036374","volume":"10","author":"G Bergers","year":"2000","unstructured":"Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 10:737\u2013744. https:\/\/doi.org\/10.1038\/35036374","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10921_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/S0022-5347(05)65752-7","volume":"166","author":"S Bernardini","year":"2001","unstructured":"Bernardini S, Fauconnet S, Chabannes E, Henry PC, Adessi G, Bittard H (2001) Serum levels of vascular endothelial growth factor as a prognostic factor in bladder cancer. J Urol 166(4):1275\u20131279","journal-title":"J Urol"},{"issue":"12","key":"10921_CR6","first-page":"3011","volume":"4","author":"FJ Bianco Jr","year":"1998","unstructured":"Bianco FJ Jr, Gervasi DC, Tiguert R, Grignon DJ, Pontes JE, Crissman JD, Fridman R, Wood DP Jr (1998) Matrix metalloproteinase-9 expression in bladder washes from bladder cancer patients predicts pathological stage and grade. Clin Cancer Res 4(12):3011\u20133016","journal-title":"Clin Cancer Res"},{"issue":"23","key":"10921_CR7","first-page":"5281","volume":"57","author":"JP Crew","year":"1997","unstructured":"Crew JP, O\u2019Brien T, Bradburn M, Fuggle S, Bicknell R, Cranston D, Harris AL (1997) Vascular endothelial growth factor is a predictor of relapse and stage progression in superficial bladder cancer. Cancer Res 57(23):5281\u20135285","journal-title":"Cancer Res"},{"key":"10921_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui N, Hu M, Khalil RA (2017) Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci 147:1\u201373. https:\/\/doi.org\/10.1016\/bs.pmbts.2017.02.005","journal-title":"Prog Mol Biol Transl Sci"},{"issue":"3","key":"10921_CR9","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/j.1432-1033.1997.00751.x","volume":"250","author":"MP d\u2019Ortho","year":"1997","unstructured":"d\u2019Ortho MP, Will H, Atkinson S, Butler G, Messent A, Gavrilovic J, Smith B, Timpl R, Zardi L, Murphy G (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250(3):751\u2013757. https:\/\/doi.org\/10.1111\/j.1432-1033.1997.00751.x","journal-title":"Eur J Biochem"},{"issue":"22","key":"10921_CR10","first-page":"5365","volume":"53","author":"B Davies","year":"1993","unstructured":"Davies B, Waxman J, Wasan H, Abel P, Williams G, Krausz T, Neal D, Thomas D, Hanby A, Balkwill F (1993) Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res 53(22):5365\u20135369","journal-title":"Cancer Res"},{"issue":"6","key":"10921_CR11","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1111\/j.1464-410x.1994.tb07122.x","volume":"74","author":"AJ Dickinson","year":"1994","unstructured":"Dickinson AJ, Fox SB, Persad RA, Hollyer J, Sibley GN, Harris AL (1994) Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas. Br J Urol 74(6):762\u2013766. https:\/\/doi.org\/10.1111\/j.1464-410x.1994.tb07122.x","journal-title":"Br J Urol"},{"key":"10921_CR12","volume-title":"World Health Organization classification of tumours, pathology and genetics of male genital organs","author":"N Eble","year":"2004","unstructured":"Eble N, Sauter G, Epstein E, Sesterhenn A (2004) World Health Organization classification of tumours, pathology and genetics of male genital organs. IARC Press, Lyon"},{"issue":"1B","key":"10921_CR13","first-page":"869","volume":"19","author":"M Edgren","year":"1999","unstructured":"Edgren M, Lennern\u00e4s B, Larsson A, Nilsson S (1999) Serum concentrations of VEGF and b-FGF in renal cell, prostate and urinary bladder carcinomas. Anticancer Res 19(1B):869\u2013873","journal-title":"Anticancer Res"},{"issue":"4","key":"10921_CR14","doi-asserted-by":"publisher","first-page":"e22275","DOI":"10.1002\/jbt.22275","volume":"33","author":"H Fouad","year":"2019","unstructured":"Fouad H, Salem H, Ellakwa DE, Abdel-Hamid M (2019) MMP-2 and MMP-9 as prognostic markers for the early detection of urinary bladder cancer. J Biochem Mol Toxicol 33(4):e22275. https:\/\/doi.org\/10.1002\/jbt.22275","journal-title":"J Biochem Mol Toxicol"},{"issue":"6","key":"10921_CR15","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.eururo.2003.12.005","volume":"45","author":"MG Friedrich","year":"2004","unstructured":"Friedrich MG, Toma MI, Petri S, Cheng JC, Hammerer P, Erbersdobler A, Huland H (2004) Expression of Maspin in non-muscle invasive bladder carcinoma: correlation with tumor angiogenesis and prognosis. Eur Urol 45(6):737\u2013743. https:\/\/doi.org\/10.1016\/j.eururo.2003.12.005","journal-title":"Eur Urol"},{"issue":"4","key":"10921_CR16","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s10555-015-9589-6","volume":"34","author":"M Garg","year":"2015","unstructured":"Garg M (2015) Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer. Cancer Metastasis Rev 34(4):691\u2013701. https:\/\/doi.org\/10.1007\/s10555-015-9589-6","journal-title":"Cancer Metastasis Rev"},{"issue":"7","key":"10921_CR17","first-page":"2583","volume":"9","author":"JC Goddard","year":"2003","unstructured":"Goddard JC, Sutton CD, Furness PN, O\u2019Byrne KJ, Kockelbergh RC (2003) Microvessel density at presentation predicts subsequent muscle invasion in superficial bladder cancer. Clin Cancer Res 9(7):2583\u20132586","journal-title":"Clin Cancer Res"},{"issue":"14","key":"10921_CR18","first-page":"3196","volume":"56","author":"K Gohji","year":"1996","unstructured":"Gohji K, Fujimoto N, Fujii A, Komiyama T, Okawa J, Nakajima M (1996) Prognostic significance of circulating matrix metalloproteinase-2 to tissue inhibitor of metalloproteinases-2 ratio in recurrence of urothelial cancer after complete resection. Cancer Res 56(14):3196\u20133198","journal-title":"Cancer Res"},{"issue":"2","key":"10921_CR19","doi-asserted-by":"publisher","first-page":"873","DOI":"10.7314\/apjcp.2013.14.2.873","volume":"14","author":"M Gunes","year":"2013","unstructured":"Gunes M, Kemik AS, Pirincci N, Gecit I, Taken K, Yuksel MB, Kaba M, Eryilmaz R (2013) Preoperative levels of matrix metalloproteinase-7 and -9 and tissue inhibitor of matrix metalloproteinase-1 relation to pathologic parameters in bladder carcinoma patients. Asian Pac J Cancer Prev 14(2):873\u2013876. https:\/\/doi.org\/10.7314\/apjcp.2013.14.2.873","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"10921_CR20","first-page":"307","volume":"22","author":"ZH Guo","year":"2003","unstructured":"Guo ZH, Mei H, Huang J, Li SY (2003) Vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) expression in superficial transitional cell bladder carcinoma. Ai Zheng 22(3):307\u2013309 (Chinese)","journal-title":"Ai Zheng"},{"issue":"5","key":"10921_CR21","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1016\/S0022-5347(05)66411-7","volume":"165","author":"I Hara","year":"2001","unstructured":"Hara I, Miyake H, Hara S, Arakawa S, Kamidono S (2001) Significance of matrix metalloproteinases and tissue inhibitors of metalloproteinase expression in the recurrence of superficial transitional cell carcinoma of the bladder. J Urol 165(5):1769\u20131772","journal-title":"J Urol"},{"issue":"6","key":"10921_CR22","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3233\/CBM-140417","volume":"14","author":"J Huang","year":"2014","unstructured":"Huang J, Ma X, Chen X, Liu X, Zhang B, Minmin L, Nie W, Zhang L, Liu L (2014) Microvessel density as a prognostic factor in bladder cancer: a systematic review of literature and meta-analysis. Cancer Biomark 14(6):505\u2013514. https:\/\/doi.org\/10.3233\/CBM-140417","journal-title":"Cancer Biomark"},{"issue":"12","key":"10921_CR23","first-page":"4866","volume":"6","author":"K Inoue","year":"2000","unstructured":"Inoue K, Slaton JW, Karashima T, Yoshikawa C, Shuin T, Sweeney P, Millikan R, Dinney CP (2000) The prognostic value of angiogenesis factor expression for predicting recurrence and metastasis of bladder cancer after neoadjuvant chemotherapy and radical cystectomy. Clin Cancer Res 6(12):4866\u20134873","journal-title":"Clin Cancer Res"},{"issue":"1","key":"10921_CR24","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3892\/or.8.1.9","volume":"8","author":"JI Izawa","year":"2001","unstructured":"Izawa JI, Slaton JW, Kedar D, Karashima T, Perrotte P, Czerniak B, Grossman HB, Dinney CP (2001) Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder. Oncol Rep 8(1):9\u201315. https:\/\/doi.org\/10.3892\/or.8.1.9","journal-title":"Oncol Rep"},{"issue":"7","key":"10921_CR25","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1002\/(SICI)1097-0142(19980401)82:7<1359::AID-CNCR20>3.0.CO;2-4","volume":"82","author":"H Kanayama","year":"1998","unstructured":"Kanayama H, Yokota K, Kurokawa Y, Murakami Y, Nishitani M, Kagawa S (1998) Prognostic values of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression in bladder cancer. Cancer 82(7):1359\u20131366","journal-title":"Cancer"},{"issue":"4","key":"10921_CR26","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1046\/j.1464-410x.2000.00734.x","volume":"86","author":"K Kanda","year":"2000","unstructured":"Kanda K, Takahashi M, Murakami Y, Kanayama H, Kagawa S (2000) The role of the activated form of matrix metalloproteinase-2 in urothelial cancer. BJU Int 86(4):553\u2013557. https:\/\/doi.org\/10.1046\/j.1464-410x.2000.00734.x","journal-title":"BJU Int"},{"issue":"6","key":"10921_CR27","first-page":"2381","volume":"33","author":"PK Kopparapu","year":"2013","unstructured":"Kopparapu PK, Boorjian SA, Robinson BD, Downes M, Gudas LJ, Mongan NP, Persson JL (2013) Expression of VEGF and its receptors VEGFR1\/VEGFR2 is associated with invasiveness of bladder cancer. Anticancer Res 33(6):2381\u20132390","journal-title":"Anticancer Res"},{"issue":"3","key":"10921_CR28","doi-asserted-by":"publisher","first-page":"956","DOI":"10.3390\/biomedicines11030956","volume":"11","author":"J Kudelski","year":"2023","unstructured":"Kudelski J, Tokarzewicz A, Gudowska-Sawczuk M, Mroczko B, Ch\u0142osta P, Bruczko-Goralewska M, Mitura P, M\u0142ynarczyk G (2023) The significance of matrix metalloproteinase 9 (MMP-9) and metalloproteinase 2 (MMP-2) in urinary bladder cancer. Biomedicines 11(3):956. https:\/\/doi.org\/10.3390\/biomedicines11030956","journal-title":"Biomedicines"},{"issue":"4","key":"10921_CR29","first-page":"856","volume":"59","author":"S Kumar","year":"1999","unstructured":"Kumar S, Ghellal A, Li C, Byrne G, Haboubi N, Wang JM, Bundred N (1999) Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res 59(4):856\u2013861","journal-title":"Cancer Res"},{"issue":"3","key":"10921_CR30","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.eururo.2015.10.024","volume":"69","author":"J Leal","year":"2016","unstructured":"Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA (2016) Economic burden of bladder cancer across the European Union. Eur Urol 69(3):438\u2013447. https:\/\/doi.org\/10.1016\/j.eururo.2015.10.024","journal-title":"Eur Urol"},{"issue":"2","key":"10921_CR31","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.oraloncology.2004.08.001","volume":"41","author":"T Martone","year":"2005","unstructured":"Martone T, Rosso P, Albera R, Migliaretti G, Fraire F, Pignataro L, Pruneri G, Bellone G, Cortesina G (2005) Prognostic relevance of CD105+ microvessel density in HNSCC patient outcome. Oral Oncol 41(2):147\u2013155. https:\/\/doi.org\/10.1016\/j.oraloncology.2004.08.001","journal-title":"Oral Oncol"},{"issue":"6","key":"10921_CR32","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1136\/jcp.2003.013508","volume":"57","author":"TC Mineo","year":"2004","unstructured":"Mineo TC, Ambrogi V, Baldi A, Rabitti C, Bollero P, Vincenzi B, Tonini G (2004) Prognostic impact of VEGF, CD31, CD34, and CD105 expression and tumour vessel invasion after radical surgery for IB-IIA non-small cell lung cancer. J Clin Pathol 57(6):591\u2013597. https:\/\/doi.org\/10.1136\/jcp.2003.013508","journal-title":"J Clin Pathol"},{"issue":"3","key":"10921_CR33","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1002\/(SICI)1097-0185(19990301)254:3<375::AID-AR8>3.0.CO;2-R","volume":"254","author":"AJ Miodo\u0144ski","year":"1999","unstructured":"Miodo\u0144ski AJ, Litwin JA (1999) Microvascular architecture of the human urinary bladder wall: a corrosion casting study. Anat Rec 254(3):375\u2013381. https:\/\/doi.org\/10.1002\/(SICI)1097-0185(19990301)254:3%3c375::AID-AR8%3e3.0.CO;2-R","journal-title":"Anat Rec"},{"issue":"3 Pt 1","key":"10921_CR34","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1158\/1078-0432.CCR-05-1284","volume":"12","author":"Y Miyata","year":"2006","unstructured":"Miyata Y, Kanda S, Ohba K, Nomata K, Hayashida Y, Eguchi J, Hayashi T, Kanetake H (2006) Lymphangiogenesis and angiogenesis in bladder cancer: prognostic implications and regulation by vascular endothelial growth factors-A, -C, and -D. Clin Cancer Res 12(3 Pt 1):800\u2013806. https:\/\/doi.org\/10.1158\/1078-0432.CCR-05-1284","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10921_CR35","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00428-013-1463-8","volume":"463","author":"Y Miyata","year":"2013","unstructured":"Miyata Y, Sagara Y, Watanabe S, Asai A, Matsuo T, Ohba K, Hayashi T, Sakai H (2013) CD105 is a more appropriate marker for evaluating angiogenesis in urothelial cancer of the upper urinary tract than CD31 or CD34. Virchows Arch 463(5):673\u2013679. https:\/\/doi.org\/10.1007\/s00428-013-1463-8","journal-title":"Virchows Arch"},{"issue":"1","key":"10921_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.eururo.2016.02.029","volume":"70","author":"H Moch","year":"2016","unstructured":"Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM (2016) The 2016 WHO classification of tumours of the urinary system and male genital organs-Part A: renal, penile, and testicular tumours. Eur Urol 70(1):93\u2013105. https:\/\/doi.org\/10.1016\/j.eururo.2016.02.029","journal-title":"Eur Urol"},{"issue":"3","key":"10921_CR37","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.cardiores.2005.12.002","volume":"69","author":"H Nagase","year":"2006","unstructured":"Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69(3):562\u2013573. https:\/\/doi.org\/10.1016\/j.cardiores.2005.12.002","journal-title":"Cardiovasc Res"},{"issue":"5","key":"10921_CR38","doi-asserted-by":"publisher","first-page":"529","DOI":"10.5980\/jpnjurol1989.89.529","volume":"89","author":"Y Ogura","year":"1998","unstructured":"Ogura Y, Sato K, Kato T, Saito K, Enomoto K (1998) Immunohistochemical analysis of expression of angiogenic factors and tumor angiogenesis in superficial bladder cancer. Nihon Hinyokika Gakkai Zasshi 89(5):529\u2013537. https:\/\/doi.org\/10.5980\/jpnjurol1989.89.529. (Japanese)","journal-title":"Nihon Hinyokika Gakkai Zasshi"},{"issue":"4","key":"10921_CR39","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1074\/jbc.272.4.2446","volume":"272","author":"E Ohuchi","year":"1997","unstructured":"Ohuchi E, Imai K, Fujii Y, Sato H, Seiki M, Okada Y (1997) Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272(4):2446\u20132451. https:\/\/doi.org\/10.1074\/jbc.272.4.2446","journal-title":"J Biol Chem"},{"key":"10921_CR40","doi-asserted-by":"publisher","first-page":"379081","DOI":"10.5402\/2012\/379081","volume":"2012","author":"H Olsson","year":"2012","unstructured":"Olsson H, Hultman P, Monsef N, Rosell J, Jahnson S (2012) Immunohistochemical evaluation of cell cycle regulators: impact on predicting prognosis in stage t1 urinary bladder cancer. ISRN Urol 2012:379081. https:\/\/doi.org\/10.5402\/2012\/379081","journal-title":"ISRN Urol"},{"issue":"4","key":"10921_CR41","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/S0022-5347(01)61684-7","volume":"161","author":"E Ozdemir","year":"1999","unstructured":"Ozdemir E, Kakehi Y, Okuno H, Yoshida O (1999) Role of matrix metalloproteinase-9 in the basement membrane destruction of superficial urothelial carcinomas. J Urol 161(4):1359\u20131363","journal-title":"J Urol"},{"issue":"3B","key":"10921_CR42","first-page":"2009","volume":"20","author":"AS Papathoma","year":"2000","unstructured":"Papathoma AS, Petraki C, Grigorakis A, Papakonstantinou H, Karavana V, Stefanakis S, Sotsiou F, Pintzas A (2000) Prognostic significance of matrix metalloproteinases 2 and 9 in bladder cancer. Anticancer Res 20(3B):2009\u20132013","journal-title":"Anticancer Res"},{"issue":"11","key":"10921_CR43","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1038\/bjc.1998.712","volume":"78","author":"SL Parsons","year":"1998","unstructured":"Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJ (1998) Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. Br J Cancer 78(11):1495\u20131502. https:\/\/doi.org\/10.1038\/bjc.1998.712","journal-title":"Br J Cancer"},{"issue":"3","key":"10921_CR44","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/j.ygyno.2008.11.013","volume":"112","author":"LM Randall","year":"2009","unstructured":"Randall LM, Monk BJ, Darcy KM, Tian C, Burger RA, Liao SY, Peters WA, Stock RJ, Fruehauf JP (2009) Markers of angiogenesis in high-risk, early-stage cervical cancer: a gynecologic oncology group study. Gynecol Oncol 112(3):583\u2013589. https:\/\/doi.org\/10.1016\/j.ygyno.2008.11.013","journal-title":"Gynecol Oncol"},{"key":"10921_CR45","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1471-2490-12-18","volume":"12","author":"ST Reis","year":"2012","unstructured":"Reis ST, Leite KR, Piovesan LF, Pontes-Junior J, Viana NI, Abe DK, Crippa A, Moura CM, Adonias SP, Srougi M, Dall\u2019Oglio MF (2012) Increased expression of MMP-9 and IL-8 are correlated with poor prognosis of bladder cancer. BMC Urol 12:18. https:\/\/doi.org\/10.1186\/1471-2490-12-18","journal-title":"BMC Urol"},{"issue":"3","key":"10921_CR46","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.ygyno.2008.11.030","volume":"112","author":"JM Rubatt","year":"2009","unstructured":"Rubatt JM, Darcy KM, Hutson A, Bean SM, Havrilesky LJ, Grace LA, Berchuck A, Secord AA (2009) Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: a gynecologic oncology group study. Gynecol Oncol 112(3):469\u2013474. https:\/\/doi.org\/10.1016\/j.ygyno.2008.11.030","journal-title":"Gynecol Oncol"},{"key":"10921_CR47","doi-asserted-by":"publisher","first-page":"102576","DOI":"10.1016\/j.bcmd.2021.102576","volume":"90","author":"A Sadaf","year":"2021","unstructured":"Sadaf A, Quinn CT, Korpik JB, Pfeiffer A, Reynaud M, Niss O, Malik P, Ware RE, Kalfa TA, McGann PT (2021) Rapid and automated quantitation of dense red blood cells: a robust biomarker of hydroxyurea treatment response. Blood Cells Mol Dis 90:102576. https:\/\/doi.org\/10.1016\/j.bcmd.2021.102576","journal-title":"Blood Cells Mol Dis"},{"issue":"12","key":"10921_CR48","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1136\/jclinpath-2011-200153","volume":"64","author":"R Seiler","year":"2011","unstructured":"Seiler R, Thalmann GN, Fleischmann A (2011) MMP-2 and MMP-9 in lymph-node-positive bladder cancer. J Clin Pathol 64(12):1078\u20131082. https:\/\/doi.org\/10.1136\/jclinpath-2011-200153","journal-title":"J Clin Pathol"},{"key":"10921_CR49","doi-asserted-by":"publisher","first-page":"115593","DOI":"10.1016\/j.taap.2021.115593","volume":"426","author":"R Siddhartha","year":"2021","unstructured":"Siddhartha R, Garg M (2021) Molecular and clinical insights of matrix metalloproteinases into cancer spread and potential therapeutic interventions. Toxicol Appl Pharmacol 426:115593. https:\/\/doi.org\/10.1016\/j.taap.2021.115593","journal-title":"Toxicol Appl Pharmacol"},{"issue":"3","key":"10921_CR50","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1158\/1535-7163.MCT-22-0595","volume":"22","author":"R Siddhartha","year":"2023","unstructured":"Siddhartha R, Garg M (2023) Interplay between extracellular matrix remodeling and angiogenesis in tumor ecosystem. Mol Cancer Ther 22(3):291\u2013305. https:\/\/doi.org\/10.1158\/1535-7163.MCT-22-0595","journal-title":"Mol Cancer Ther"},{"issue":"2","key":"10921_CR51","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/ijms18020418","volume":"18","author":"V Simone","year":"2017","unstructured":"Simone V, Brunetti O, Lupo L, Testini M, Maiorano E, Simone M, Longo V, Rolfo C, Peeters M, Scarpa A, Azzariti A, Russo A, Ribatti D, Silvestris N (2017) Targeting angiogenesis in biliary tract cancers: an open option. Int J Mol Sci 18(2):418. https:\/\/doi.org\/10.3390\/ijms18020418","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10921_CR52","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s12307-017-0199-4","volume":"11","author":"R Singh","year":"2018","unstructured":"Singh R, Mandhani A, Agrawal V, Garg M (2018) Positive correlation between matrix metalloproteinases and epithelial-to-mesenchymal transition and its association with clinical outcome in bladder cancer patients. Cancer Microenviron 11(1):23\u201339. https:\/\/doi.org\/10.1007\/s12307-017-0199-4","journal-title":"Cancer Microenviron"},{"issue":"3","key":"10921_CR53","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"10921_CR54","doi-asserted-by":"publisher","first-page":"4513","DOI":"10.1002\/cncr.25401","volume":"116","author":"RS Svatek","year":"2010","unstructured":"Svatek RS, Shah JB, Xing J, Chang D, Lin J, McConkey DJ, Wu X, Dinney CP (2010) A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer. Cancer 116(19):4513\u20134519. https:\/\/doi.org\/10.1002\/cncr.25401","journal-title":"Cancer"},{"issue":"11","key":"10921_CR55","first-page":"3410","volume":"7","author":"F Tanaka","year":"2001","unstructured":"Tanaka F, Otake Y, Yanagihara K, Kawano Y, Miyahara R, Li M, Yamada T, Hanaoka N, Inui K, Wada H (2001) Evaluation of angiogenesis in non-small cell lung cancer: comparison between anti-CD34 antibody and anti-CD105 antibody. Clin Cancer Res 7(11):3410\u20133415","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10921_CR56","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S0002-9440(10)64887-0","volume":"160","author":"G Taraboletti","year":"2002","unstructured":"Taraboletti G, D\u2019Ascenzo S, Borsotti P, Giavazzi R, Pavan A, Dolo V (2002) Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells. Am J Pathol 160(2):673\u2013680. https:\/\/doi.org\/10.1016\/S0002-9440(10)64887-0","journal-title":"Am J Pathol"},{"issue":"2","key":"10921_CR57","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nrc2780","volume":"10","author":"N Turner","year":"2010","unstructured":"Turner N, Grose R (2010) Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer 10(2):116\u2013129. https:\/\/doi.org\/10.1038\/nrc2780","journal-title":"Nat Rev Cancer"},{"issue":"3","key":"10921_CR58","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.eururo.2009.06.028","volume":"56","author":"BW van Rhijn","year":"2009","unstructured":"van Rhijn BW, Burger M, Lotan Y, Solsona E, Stief CG, Sylvester RJ, Witjes JA, Zlotta AR (2009) Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy. Eur Urol 56(3):430\u2013442. https:\/\/doi.org\/10.1016\/j.eururo.2009.06.028","journal-title":"Eur Urol"},{"issue":"5","key":"10921_CR59","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/s0090-4295(03)00660-5","volume":"62","author":"K Vasala","year":"2003","unstructured":"Vasala K, P\u00e4\u00e4kk\u00f6 P, Turpeenniemi-Hujanen T (2003) Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer. Urology 62(5):952\u2013957. https:\/\/doi.org\/10.1016\/s0090-4295(03)00660-5","journal-title":"Urology"},{"issue":"3B","key":"10921_CR60","first-page":"1757","volume":"28","author":"K Vasala","year":"2008","unstructured":"Vasala K, P\u00e4\u00e4kko P, Turpeenniemi-Hujanen T (2008) Matrix metalloproteinase-9 (MMP-9) immunoreactive protein in urinary bladder cancer: a marker of favorable prognosis. Anticancer Res 28(3B):1757\u20131761","journal-title":"Anticancer Res"},{"issue":"1","key":"10921_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1056\/NEJM199101033240101","volume":"324","author":"N Weidner","year":"1991","unstructured":"Weidner N, Semple JP, Welch WR, Folkman J (1991) Tumor angiogenesis and metastasis\u2013correlation in invasive breast carcinoma. N Engl J Med 324(1):1\u20138. https:\/\/doi.org\/10.1056\/NEJM199101033240101","journal-title":"N Engl J Med"},{"issue":"18","key":"10921_CR62","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.clinbiochem.2015.07.021","volume":"48","author":"E Wieczorek","year":"2015","unstructured":"Wieczorek E, Jablonowski Z, Tomasik B, Konecki T, Jablonska E, Gromadzinska J, Fendler W, Sosnowski M, Wasowicz W, Reszka E (2015) MMP, VEGF and TIMP as prognostic factors in recurring bladder cancer. Clin Biochem 48(18):1235\u20131240. https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.07.021","journal-title":"Clin Biochem"},{"issue":"Supplement","key":"10921_CR63","doi-asserted-by":"publisher","first-page":"S54","DOI":"10.4103\/0973-1482.163761","volume":"14","author":"GJ Wu","year":"2018","unstructured":"Wu GJ, Bao JS, Yue ZJ, Zeng FC, Cen S, Tang ZY, Kang XL (2018) Elevated expression of matrix metalloproteinase-9 is associated with bladder cancer pathogenesis. J Cancer Res Ther 14(Supplement):S54\u2013S59. https:\/\/doi.org\/10.4103\/0973-1482.163761","journal-title":"J Cancer Res Ther"},{"issue":"4","key":"10921_CR64","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0022-5347(05)00736-6","volume":"175","author":"G Xia","year":"2006","unstructured":"Xia G, Kumar SR, Hawes D, Cai J, Hassanieh L, Groshen S, Zhu S, Masood R, Quinn DI, Broek D, Stein JP, Gill PS (2006) Expression and significance of vascular endothelial growth factor receptor 2 in bladder cancer. J Urol 175(4):1245\u20131252. https:\/\/doi.org\/10.1016\/S0022-5347(05)00736-6","journal-title":"J Urol"},{"issue":"1","key":"10921_CR65","first-page":"39","volume":"37","author":"Y Yao","year":"2007","unstructured":"Yao Y, Pan Y, Chen J, Sun X, Qiu Y, Ding Y (2007) Endoglin (CD105) expression in angiogenesis of primary hepatocellular carcinomas: analysis using tissue microarrays and comparisons with CD34 and VEGF. Ann Clin Lab Sci 37(1):39\u201348","journal-title":"Ann Clin Lab Sci"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10921-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10921-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10921-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T07:13:43Z","timestamp":1758957223000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10921-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10921"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10921-3","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"value":"0006-2928","type":"print"},{"value":"1573-4927","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"2 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}},{"value":"Studies were performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki. Ethical clearance was obtained from the institutional bioethical cell (Institutional Ethical Committee Ref no.115thECM IIA\/P3) at KGMU, Lucknow.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Analysis used anonymous data that were obtained after each patient agreed to participate in the study. A written informed consent was taken from each patient or their immediate family member.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}}]}}